TAK
TAK
US8740602052
Takeda Pharmaceutical Company L
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
59.83B EUR
25.33B EUR
29.26B EUR
24.63B EUR
Enterprise Value
5.14T EUR
4.5T EUR
4.32T EUR
4.22T EUR
Valuation Multiples
Trailing P/E
--
--
--
0.11x
Forward P/E
35.34x
--
--
--
Price to Sales
0.01x
0.01x
0.01x
0.01x
Price to Book
1.24x
0x
0x
0x
EV/Revenue
1.11x
0.98x
0.96x
1.24x
EV/EBITDA
4.11x
6.98x
6.19x
3.66x
Price to FCF (P/FCF)
0.11x
0.05x
0.06x
0.05x
EV/FCF
9.48x
9.26x
8.87x
8.86x
FCF Yield
904.9%
1,920.66%
1,663.21%
1,934.94%
ende